The patient reports an allergy to latex. what alterations should be made in the patients care

1. Fasting S, Gisvold SE. [Serious intraoperative problems – a five-year review of 83,844 anesthetics] Can J Anaesth. 2002;49:545–53. [PubMed] [Google Scholar]

2. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol. 2002;19:240–62. [PubMed] [Google Scholar]

3. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth. 2001;87:549–58. [PubMed] [Google Scholar]

4. Harboe T, Guttormsen AB, Irgens A, Dybendal T, Florvaag E. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology. 2005;102:897–903. [PubMed] [Google Scholar]

5. Chong YY, Caballero MR, Lukawska J, Dugue P. Anaphylaxis during general anaesthesia: one-year survey from a British allergy clinic. Singapore Med J. 2008;49:483–7. [PubMed] [Google Scholar]

6. Currie M, Webb RK, Williamson JA, Russell WJ, Mackay P, The Australian Incident Monitoring Study Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care. 1993;21:621–5. [PubMed] [Google Scholar]

7. Kroigaard M, Garvey LH, Gillberg L, Johansson SG, Mosbech H, Florvaag E, Harboe T, Eriksson LI, Dahlgren G, Seeman-Lodding H, Takala R, Wattwil M, Hirlekar G, Dahlen B, Guttormsen AB. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand. 2007;51:655–70. [PubMed] [Google Scholar]

8. Harper NJ, Dixon T, Dugue P, Edgar DM, Fay A, Gooi HC, Herriot R, Hopkins P, Hunter JM, Mirakian R, Pumphrey RS, Seneviratne SL, Walls AF, Williams P, Wildsmith JA, Wood P, Nasser AS, Powell RK, Mirakhur R, Soar J. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia. 2009;64:199–211. [PMC free article] [PubMed] [Google Scholar]

9. Coombs PGHGRRA. Clinical Aspects of Immunology. 3rd edn. Oxford: Blackwell Scientific; 1975. [Google Scholar]

10. Whittingham S, Mackey IR. Adverse reactions to drugs: relationship to immunopathic disease. Med J Aust. 1976;1:486–8. 90–2. [PubMed] [Google Scholar]

11. Gell PGH, Coombs RRA. Clinical Aspects of Immunology. Oxford: Blackwell; 1963. [Google Scholar]

12. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6. [PubMed] [Google Scholar]

13. Ogawa Y, Grant JA. Mediators of anaphylaxis. Immunol Allergy Clin North Am. 2007;27:249–60. [PubMed] [Google Scholar]

14. Schleimer RP, Fox CC, Naclerio RM, Plaut M, Creticos PS, Togias AG, Warner JA, Kagey-Sobotka A, Lichtenstein LM. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985;76:369–74. [PubMed] [Google Scholar]

15. Piper PJ. Effects of the released mediators of anaphylaxis on the target organs. Scand J Respir Dis Suppl. 1977;98:40–6. [PubMed] [Google Scholar]

16. Fesus L, Csaba B, Muszbek L. Platelet activating factor, the trigger of haemostatic alterations in rat anaphylaxis. Clin Exp Immunol. 1977;27:512–5. [PMC free article] [PubMed] [Google Scholar]

17. Oliver JM, Kepley CL, Ortega E, Wilson BS. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway. Immunopharmacology. 2000;48:269–81. [PubMed] [Google Scholar]

18. Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SG. Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol. 2009;124:786–92. e4. [PubMed] [Google Scholar]

19. Dachman WD, Bedarida G, Blaschke TF, Hoffman BB. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J Allergy Clin Immunol. 1994;93:606–14. [PubMed] [Google Scholar]

20. Beasley RC, Featherstone RL, Church MK, Rafferty P, Varley JG, Harris A, Robinson C, Holgate ST. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J Appl Physiol. 1989;66:1685–93. [PubMed] [Google Scholar]

21. Feuerstein G, Hallenbeck JM. Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol. 1987;27:301–13. [PubMed] [Google Scholar]

22. Triggiani M, Patella V, Staiano RI, Granata F, Marone G. Allergy and the cardiovascular system. Clin Exp Immunol. 2008;153(Suppl 1):7–11. [PMC free article] [PubMed] [Google Scholar]

23. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr, Bock SA, Branum A, Brown SG, Camargo CA, Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD, Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW. Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391–7. [PubMed] [Google Scholar]

24. Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol. 2009;124:639–46. quiz 47–8. [PMC free article] [PubMed] [Google Scholar]

25. Katsanos GS, Anogeianaki A, Orso C, Tete S, Salini V, Antinolfi PL, Sabatino G. Mast cells and chemokines. J Biol Regul Homeost Agents. 2008;22:145–51. [PubMed] [Google Scholar]

26. Levy JH, Roizen MF, Morris JM. Anaphylactic and anaphylactoid reactions. A review. Spine (Phila Pa 1976) 1986;11:282–91. [PubMed] [Google Scholar]

27. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wuthrich B. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813–24. [PubMed] [Google Scholar]

28. Ewan PW, Dugue P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy. 2010;40:15–31. [PubMed] [Google Scholar]

29. Hunting AS, Nopp A, Johansson SG, Andersen F, Wilhelmsen V, Guttormsen AB. Anaphylaxis to Patent Blue V. I. Clinical aspects. Allergy. 2010;65:117–23. [PubMed] [Google Scholar]

30. Levy JH, Adkinson NF., Jr Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg. 2008;106:392–403. [PubMed] [Google Scholar]

31. Gandhi R, Sharma B, Sood J. Severe anaphylaxis during general anaesthesia in a beta-blocked cardiac patient: considerations. Acta Anaesthesiol Scand. 2008;52:574. [PubMed] [Google Scholar]

32. Jee R, Nel L, Gnanakumaran G, Williams A, Eren E. Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth. 2009;103:614–5. [PubMed] [Google Scholar]

33. Wang CC, Chang SH, Chen CC, Huang HL, Hsieh IC. Severe coronary artery spasm with anaphylactoid shock caused by contrast medium – case reports. Angiology. 2006;57:225–9. [PubMed] [Google Scholar]

34. Kroigaard M, Garvey LH, Menne T, Husum B. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing? Br J Anaesth. 2005;95:468–71. [PubMed] [Google Scholar]

35. De Souza RL, Short T, Warman GR, Maclennan N, Young Y. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography. Anaesth Intensive Care. 2004;32:580–7. [PubMed] [Google Scholar]

36. Hogan AD, Schwartz LB. Markers of mast cell degranulation. Methods. 1997;13:43–52. [PubMed] [Google Scholar]

37. Laroche D, Vergnaud MC, Sillard B, Soufarapis H, Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesthesiology. 1991;75:945–9. [PubMed] [Google Scholar]

38. Jogie-Brahim S, Min HK, Fukuoka Y, Xia HZ, Schwartz LB. Expression of alpha-tryptase and beta-tryptase by human basophils. J Allergy Clin Immunol. 2004;113:1086–92. [PubMed] [Google Scholar]

39. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695–703. [PubMed] [Google Scholar]

40. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand. 2003;47:1211–8. [PubMed] [Google Scholar]

41. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;26:451–63. [PubMed] [Google Scholar]

42. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Muller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF. [Comment on ‘Systemic mastocytosis and anesthesia: a case report’] Rev Esp Anestesiol Reanim. 2008;55:385–6. author reply 6–7. [Google Scholar]

43. Vaughan ST, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia. 1998;53:804–7. [PubMed] [Google Scholar]

44. Rosenbaum KJ, Strobel GE. Anesthetic considerations in mastocytosis. Anesthesiology. 1973;38:398–401. [PubMed] [Google Scholar]

45. Mertes PM, Laxenaire MC. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol. 2004;70:285–91. [PubMed] [Google Scholar]

47. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Muller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120(1) Suppl.:S2–24. [PubMed] [Google Scholar]

48. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas. 2004;16:120–4. [PubMed] [Google Scholar]

49. Zhou XY, Buckley MG, Lau LC, Summers C, Pumphrey RSH, Walls AF. Mast cell carboxypeptidase as a new clinical marker for anaphylaxis. J Allergy Clin Immunol. 2006;117:s85. [abstract] [Google Scholar]

50. Agis H, Krauth MT, Bohm A, Mosberger I, Mullauer L, Simonitsch-Klupp I, Walls AF, Horny HP, Valent P. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders. Am J Clin Pathol. 2006;125:273–81. [PubMed] [Google Scholar]

51. Mochizuki A, McEuen AR, Buckley MG, Walls AF. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation. J Allergy Clin Immunol. 2003;112:102–8. [PubMed] [Google Scholar]

52. Wide L. Clinical significance of measurement of reaginic (IgE) antibody by RAST. Clin Allergy. 1973;3(Suppl.):583–95. [PubMed] [Google Scholar]

53. Kraft D, Wide L. Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy. Br J Dermatol. 1976;94:593–601. [PubMed] [Google Scholar]

54. Ewan PW, Coote D. Evaluation of a capsulated hydrophilic carrier polymer (the ImmunoCAP) for measurement of specific IgE antibodies. Allergy. 1990;45:22–9. [PubMed] [Google Scholar]

55. Ebo DG, Venemalm L, Bridts CH, Degerbeck F, Hagberg H, De Clerck LS, Stevens WJ. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. Anesthesiology. 2007;107:253–9. [PubMed] [Google Scholar]

56. Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy. 2007;62:471–87. [PubMed] [Google Scholar]

57. Fontaine C, Mayorga C, Bousquet PJ, Arnoux B, Torres MJ, Blanca M, Demoly P. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy. 2007;62:47–52. [PubMed] [Google Scholar]

58. Guttormsen AB, Johansson SG, Oman H, Wilhelmsen V, Nopp A. No consumption of IgE antibody in serum during allergic drug anaphylaxis. Allergy. 2007;62:1326–30. [PubMed] [Google Scholar]

59. Juhlin L. Basophil leukocyte differential in blood and bone marrow. Acta Haematol. 1963;29:89–95. [PubMed] [Google Scholar]

60. De Week AL, Sanz ML, Gamboa PM, Aberer W, Sturm G, Bilo MB, Montroni M, Blanca M, Torres MJ, Mayorga L, Campi P, Manfredi M, Drouet M, Sainte-Laudy J, Romano A, Merk H, Weber JM, Jermann TM. Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study. J Investig Allergol Clin Immunol. 2009;19:91–109. [PubMed] [Google Scholar]

61. Rudolf M, Milavec-Puretic V, Lipozencic J, Malenica B. Clinical usefulness of cellular antigen stimulation test in detection of aspirin allergy. Acta Dermatovenerol Croat. 2005;13:93–6. [PubMed] [Google Scholar]

62. De Week AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, Sainte Laudy J. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol. 2008;18:143–55. [PubMed] [Google Scholar]

63. Hausmann OV, Gentinetta T, Bridts CH, Ebo DG. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin North Am. 2009;29:555–66. [PubMed] [Google Scholar]

64. Bavbek S, Ikinciogullari A, Dursun AB, Guloglu D, Arikan M, Elhan AH, Misirligil Z. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol. 2009;150:261–70. [PubMed] [Google Scholar]

65. Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet PJ, Merk HF, Sanz ML, Ott H, Atanaskovic-Markovic M. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64:183–93. [PubMed] [Google Scholar]

66. Sanz ML, Gamboa PM, Mayorga C. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol. 2009;9:298–304. [PubMed] [Google Scholar]

67. Rodriguez-Trabado A, Camara-Hijon C, Ramos-Cantarino A, Porcel-Carreno SL, Jimenez-Timon S, Pereira-Navarro G, Hernandez-Arbeiza FJ, Fernandez-Pereira L. Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc. 2008;29:241–9. [PubMed] [Google Scholar]

68. Dewachter P, Mouton-Faivre C. What investigation after an anaphylactic reaction during anaesthesia? Curr Opin Anaesthesiol. 2008;21:363–8. [PubMed] [Google Scholar]

69. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugue P, Friedmann PS, English JS, Huber PA, Nasser SM. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009;39:43–61. [PubMed] [Google Scholar]

70. Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology. 2009;111:1141–50. [PubMed] [Google Scholar]

71. Aberer W, Kranke B. Provocation tests in drug hypersensitivity. Immunol Allergy Clin North Am. 2009;29:567–84. [PubMed] [Google Scholar]

72. Bousquet PJ, Gaeta F, Bousquet-Rouanet L, Lefrant JY, Demoly P, Romano A. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des. 2008;14:2792–802. [PubMed] [Google Scholar]

73. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wohrl S, Dahlen B, Szczeklik A. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62:1111–8. [PubMed] [Google Scholar]

74. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, Brockow K, Pichler WJ, Demoly P. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58:854–63. [PubMed] [Google Scholar]

75. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth. 2001;86:678–82. [PubMed] [Google Scholar]

76. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology. 2003;99:536–45. [PubMed] [Google Scholar]

77. Florvaag E, Johansson SG. The pholcodine story. Immunol Allergy Clin North Am. 2009;29:419–27. [PubMed] [Google Scholar]

78. Fraser BA, Smart JA. Anaphylaxis to cisatracurium following negative skin testing. Anaesth Intensive Care. 2005;33:816–9. [PubMed] [Google Scholar]

79. Mertes PM, Lambert M, Gueant-Rodriguez RM, Aimone-Gastin I, Mouton-Faivre C, Moneret-Vautrin DA, Gueant JL, Malinovsky JM, Demoly P. Perioperative anaphylaxis. Immunol Allergy Clin North Am. 2009;29:429–51. [PubMed] [Google Scholar]

80. Lobera T, Audicana MT, Pozo MD, Blasco A, Fernandez E, Canada P, Gastaminza G, Martinez-Albelda I, Gonzalez-Mahave I, Munoz D. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain. J Investig Allergol Clin Immunol. 2008;18:350–6. [PubMed] [Google Scholar]

81. Deval R, Ramesh V, Prasad GB, Jain AK. Natural rubber latex allergy. Indian J Dermatol Venereol Leprol. 2008;74:304–10. [PubMed] [Google Scholar]

82. Cremer R, Lorbacher M, Hering F, Engelskirchen R. Natural rubber latex sensitisation and allergy in patients with spina bifida, urogenital disorders and oesophageal atresia compared with a normal paediatric population. Eur J Pediatr Surg. 2007;17:194–8. [PubMed] [Google Scholar]

83. Waseem M, Ganti S, Hipp A, Ravi L. Latex-induced anaphylactic reaction in a child with spina bifida. Pediatr Emerg Care. 2006;22:441–2. [PubMed] [Google Scholar]

85. Suli C, Lorini M, Mistrello G, Tedeschi A. Diagnosis of latex hypersensitivity: comparison of different methods. Eur Ann Allergy Clin Immunol. 2006;38:24–30. [PubMed] [Google Scholar]

86. Taylor JS, Erkek E. Latex allergy: diagnosis and management. Dermatol Ther. 2004;17:289–301. [PubMed] [Google Scholar]

87. Kurup VP, Fink JN. The spectrum of immunologic sensitization in latex allergy. Allergy. 2001;56:2–12. [PubMed] [Google Scholar]

88. Incorvaia C, Mauro M, Cappelletti T, Pravettoni C, Leo G, Riario-Sforza GG. New applications for sublingual immunotherapy in allergy. Recent Pat Inflamm Allergy Drug Discov. 2009;3:113–7. [PubMed] [Google Scholar]

89. Pereira C, Pedro E, Tavares B, Ferreira MB, Carrapatoso I, Rico P, Loureiro G, Rodrigues F, Santos MC, Palma-Carlos AG, Chieira C. Specific immunotherapy for severe latex allergy. Eur Ann Allergy Clin Immunol. 2003;35:217–25. [PubMed] [Google Scholar]

90. Silva R, Cruz L, Botelho C, Cadinha S, Castro E, Rodrigues J, Castel-Branco MG. Work up of patients with history of beta-lactam hypersensitivity. Allergol Immunopathol (Madr) 2009;37:193–7. [PubMed] [Google Scholar]

91. Dewachter P, Mouton-Faivre C. Skin testing performed in individuals cannot be compared with responses from anaphylactic patients. Anesth Analg. 2008;107:1441. author reply. [PubMed] [Google Scholar]

92. Torres MJ, Mayorga C, Leyva L, Guzman AE, Cornejo-Garcia JA, Juarez C, Blanca M. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy. 2002;32:270–6. [PubMed] [Google Scholar]

93. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of beta-lactam antibiotics. Drug Saf. 1994;10:318–27. [PubMed] [Google Scholar]

94. Zhao Z, Baldo BA, Rimmer J. Beta-lactam allergenic determinants: fine structural recognition of a cross-reacting determinant on benzylpenicillin and cephalothin. Clin Exp Allergy. 2002;32:1644–50. [PubMed] [Google Scholar]

95. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg. 2007;136:340–7. [PubMed] [Google Scholar]

96. Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montanez MI, Fernandez T, Blanca M. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol. 2006;117:404–10. [PubMed] [Google Scholar]

97. Duffy BL. Vancomycin reaction during spinal anaesthesia. Anaesth Intensive Care. 2002;30:364–6. [PubMed] [Google Scholar]

98. Anne S, Middleton E, Jr, Reisman RE. Vancomycin anaphylaxis and successful desensitization. Ann Allergy. 1994;73:402–4. [PubMed] [Google Scholar]

99. Venemalm L, Degerbeck F, Smith W. IgE-mediated reaction to mepivacaine. J Allergy Clin Immunol. 2008;121:1058–9. [PubMed] [Google Scholar]

100. Vu AT, Lockey RF. Benzocaine anaphylaxis. J Allergy Clin Immunol. 2006;118:534–5. [PubMed] [Google Scholar]

101. Grosman N. Histamine release from isolated rat mast cells: effect of morphine and related drugs and their interaction with compound 48/80. Agents Actions. 1981;11:196–203. [PubMed] [Google Scholar]

102. Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ. Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol. 1987;79:646–53. [PubMed] [Google Scholar]

103. Ebertz JM, Hermens JM, McMillan JC, Uno H, Hirshman C, Hanifin JM. Functional differences between human cutaneous mast cells and basophils: a comparison of morphine-induced histamine release. Agents Actions. 1986;18:455–62. [PubMed] [Google Scholar]

104. Harle DG, Baldo BA, Coroneos NJ, Fisher MM. Anaphylaxis following administration of papaveretum. Case report: Implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant. Anesthesiology. 1989;71:489–94. [PubMed] [Google Scholar]

105. Nasser SM, Ewan PW. Opiate-sensitivity: clinical characteristics and the role of skin prick testing. Clin Exp Allergy. 2001;31:1014–20. [PubMed] [Google Scholar]

106. Cummings KC, 3rd, Arnaut K. Case report: fentanyl-associated intraoperative anaphylaxis with pulmonary edema. Can J Anaesth. 2007;54:301–6. [PubMed] [Google Scholar]

107. Bennett MJ, Anderson LK, McMillan JC, Ebertz JM, Hanifin JM, Hirshman CA. Anaphylactic reaction during anaesthesia associated with positive intradermal skin test to fentanyl. Can Anaesth Soc J. 1986;33:75–8. [PubMed] [Google Scholar]

108. Dewachter P, Lefebvre D, Kalaboka S, Bloch-Morot E. An anaphylactic reaction to transdermal delivered fentanyl. Acta Anaesthesiol Scand. 2009;53:1092–3. [PubMed] [Google Scholar]

109. Beaudouin E, Kanny G, Morisset M, Renaudin JM, Mertes M, Laxenaire MC, Mouton C, Jacson F, Moneret-Vautrin DA. Immediate hypersensitivity to chlorhexidine: literature review. Eur Ann Allergy Clin Immunol. 2004;36:123–6. [PubMed] [Google Scholar]

110. Garvey LH, Roed-Petersen J, Husum B. Anaphylactic reactions in anaesthetised patients – four cases of chlorhexidine allergy. Acta Anaesthesiol Scand. 2001;45:1290–4. [PubMed] [Google Scholar]

111. Kluger M. Anaphylaxis to chlorhexidine-impregnated central venous catheter. Anaesth Intensive Care. 2003;31:697–8. [PubMed] [Google Scholar]

112. Pittaway A, Ford S. Allergy to chlorhexidine-coated central venous catheters revisited. Br J Anaesth. 2002;88:304–5. author reply 5. [PubMed] [Google Scholar]

113. Stephens R, Mythen M, Kallis P, Davies DW, Egner W, Rickards A. Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter. Br J Anaesth. 2001;87:306–8. [PubMed] [Google Scholar]

114. Ebo DG, Bridts CH, Stevens WJ. Anaphylaxis to an urethral lubricant: chlorhexidine as the ‘hidden’ allergen. Acta Clin Belg. 2004;59:358–60. [PubMed] [Google Scholar]

115. Jayathillake A, Mason DF, Broome K. Allergy to chlorhexidine gluconate in urethral gel: report of four cases and review of the literature. Urology. 2003;61:837. [PubMed] [Google Scholar]

116. Parker F, Foran S. Chlorhexidine catheter lubricant anaphylaxis. Anaesth Intensive Care. 1995;23:126. [PubMed] [Google Scholar]

117. Russ BR, Maddern PJ. Anaphylactic reaction to chlorhexidine in urinary catheter lubricant. Anaesth Intensive Care. 1994;22:611–2. [PubMed] [Google Scholar]

118. Aalto-Korte K, Makinen-Kiljunen S. Symptoms of immediate chlorhexidine hypersensitivity in patients with a positive prick test. Contact Dermatitis. 2006;55:173–7. [PubMed] [Google Scholar]

119. Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol. 2006;96:497–500. [PubMed] [Google Scholar]

120. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, Feig BW, Ross MI, Kuerer HM. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393–8. [PubMed] [Google Scholar]

121. Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, Domino EF. Allergic reactions to isosulfan blue during sentinel node biopsy – a common event. Surgery. 2001;130:439–42. [PubMed] [Google Scholar]

122. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000;7:361–6. [PubMed] [Google Scholar]

123. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, Marshall GD, Jr, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005;104:692–9. [PubMed] [Google Scholar]

124. Kalimo K, Jansen CT, Kormano M. Sensitivity to patent blue dye during skin-prick testing and lymphography. A retrospective and prospective study. Radiology. 1981;141:365–7. [PubMed] [Google Scholar]

125. Kalimo K, Saarni H. Immediate reactions to patent blue dye. Contact Dermatitis. 1981;7:171–2. [PubMed] [Google Scholar]

126. Quiliquini A, Hogendijk S, Hauser C. Anapylaxis to patent blue. Dermatology. 1998;197:400. [PubMed] [Google Scholar]

127. Dewachter P, Mouton-Faivre C, Benhaijoub A, Abel-Decollogne F, Mertes PM. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol Scand. 2006;50:245–7. [PubMed] [Google Scholar]

128. Laxenaire MC, Charpentier C, Feldman L. [Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study] Ann Fr Anesth Reanim. 1994;13:301–10. [PubMed] [Google Scholar]

129. Russell WJ, Fenwick DG. Anaphylaxis to Haemaccel and cross reactivity to Gelofusin. Anaesth Intensive Care. 2002;30:481–3. [PubMed] [Google Scholar]

130. Nybo M, Madsen JS. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol. 2008;103:192–6. [PubMed] [Google Scholar]

131. Weiler JM, Gellhaus MA, Carter JG, Meng RL, Benson PM, Hottel RA, Schillig KB, Vegh AB, Clarke WR. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol. 1990;85:713–9. [PubMed] [Google Scholar]

132. Nyhan DP, Shampaine EL, Hirshman CA, Hamilton RG, Frank SM, Baumgartner WA, Adkinson NF., Jr Single doses of intravenous protamine result in the formation of protamine-specific IgE and IgG antibodies. J Allergy Clin Immunol. 1996;97:991–7. [PubMed] [Google Scholar]

133. Kindler C, Bircher A, Stulz P. Protamine-induced fulminating non-cardiogenic pulmonary edema following cardiopulmonary bypass. Eur J Cardiothorac Surg. 1996;10:463–6. [PubMed] [Google Scholar]

134. Weiss ME, Adkinson NF., Jr Allergy to protamine. Clin Rev Allergy. 1991;9:339–55. [PubMed] [Google Scholar]

135. Knape JT, Schuller JL, de Haan P, de Jong AP, Bovill JG. An anaphylactic reaction to protamine in a patient allergic to fish. Anesthesiology. 1981;55:324–5. [PubMed] [Google Scholar]

136. Greenberger PA, Patterson R, Tobin MC, Liotta JL, Roberts M. Lack of cross-reactivity between IgE to salmon and protamine sulfate. Am J Med Sci. 1989;298:104–8. [PubMed] [Google Scholar]

137. Levy JH, Schwieger IM, Zaidan JR, Faraj BA, Weintraub WS. Evaluation of patients at risk for protamine reactions. J Thorac Cardiovasc Surg. 1989;98:200–4. [PubMed] [Google Scholar]

138. Gupta SK, Veith FJ, Ascer E, Wengerter KR, Franco C, Amar D, el-Gaweet ES, Gupta A. Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery. J Vasc Surg. 1989;9:342–50. [PubMed] [Google Scholar]

139. Ellerhorst JA, Comstock JP, Nell LJ. Protamine antibody production in diabetic subjects treated with NPH insulin. Am J Med Sci. 1990;299:298–301. [PubMed] [Google Scholar]

140. Vincent GM, Janowski M, Menlove R. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations. Cathet Cardiovasc Diagn. 1991;23:164–8. [PubMed] [Google Scholar]

141. Doolan L, McKenzie I, Krafchek J, Parsons B, Buxton B. Protamine sulphate hypersensitivity. Anaesth Intensive Care. 1981;9:147–9. [PubMed] [Google Scholar]

142. McHale SP, Konieczko K. Anaphylactoid reaction to propofol. Anaesthesia. 1992;47:864–5. [PubMed] [Google Scholar]

143. Harle DG, Baldo BA, Smal MA, Wajon P, Fisher MM. Detection of thiopentone-reactive IgE antibodies following anaphylactoid reactions during anaesthesia. Clin Allergy. 1986;16:493–8. [PubMed] [Google Scholar]

144. Baldwin AC. Thiopentone anaphylaxis. Anaesthesia. 1979;34:333–5. [PubMed] [Google Scholar]

Which of the following patients are at risk for developing an infection?

Which symptoms indicates the presence of a systemic infection?

Which of the following may be signs of a localized infection?

What do you do if the gauze lands touching the one inch border of the sterile field when you are setting up for a sterile dressing change?